Literature DB >> 28539275

Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.

Ying Liu1, Jinguang Liu1, Jun Liang1, Meiying Zhang1, Zhe Li1, Zhi Wang1, Beilei Dang1, Nianping Feng2.   

Abstract

Wheat germ agglutinin-modified lipid-polymer hybrid nanoparticles (WGA-LPNs) promote cellular uptake after oral delivery via receptor-mediated endocytosis and bioadhesion. Understanding the mucosal transport of WGA-LPNs would help to improve bioavailability and ensure therapeutic efficacy. In this study, WGA-LPNs interacted with mucin, forming larger agglomerates with intact core-shell structure. The interaction of WGA-LPNs with mucin improved enterocyte endocytosis in Caco-2 cells. An in situ intestinal diffusion study in mice confirmed that WGA-LPNs reached enterocytes and underwent endocytosis, despite interference from mucin. Importantly, oral bioavailability of oridonin-loaded WGA-LPNs increased by 1.96-fold compared with that of LPNs. Furthermore, oral administration of WGA-LPNs inhibited tumor growth in HepG2 xenograft nude mice. In addition to elucidating interactions between WGA-LPNs and mucin, these results indicated that WGA-LPNs might act as promising nanocarriers for oral delivery of drugs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antitumor effect; Bioavailability; Mucus diffusion; Wheat germ agglutinin-modified lipid–polymer hybrid nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28539275     DOI: 10.1016/j.nano.2017.05.003

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  7 in total

Review 1.  Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape.

Authors:  Ali Kermanizadeh; Leagh G Powell; Vicki Stone; Peter Møller
Journal:  Int J Nanomedicine       Date:  2018-11-16

2.  Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.

Authors:  Nayab Tahir; Asadullah Madni; Alexandra Correia; Mubashar Rehman; Vimalkumar Balasubramanian; Muhammad Muzamil Khan; Hélder A Santos
Journal:  Int J Nanomedicine       Date:  2019-07-05

3.  Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.

Authors:  Ying Liu; Xingmei Xie; Xuefeng Hou; Junyi Shen; Jiangpei Shi; Haizhen Chen; Yuanzhi He; Zhi Wang; Nianping Feng
Journal:  J Nanobiotechnology       Date:  2020-05-30       Impact factor: 10.435

4.  Preparation, Characterization, and In Vitro Release of Curcumin-Loaded IRMOF-10 Nanoparticles and Investigation of Their Pro-Apoptotic Effects on Human Hepatoma HepG2 Cells.

Authors:  Dongge Yin; Xueling Hu; Mengru Cai; Kaixin Wang; Hulinyue Peng; Jie Bai; Yvchen Xv; Tingting Fu; Xiaoxv Dong; Jian Ni; Xingbin Yin
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

5.  Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.

Authors:  Gongsen Chen; Juyuan Luo; Mengru Cai; Liuying Qin; Yibo Wang; Lili Gao; Pingqing Huang; Yingchao Yu; Yangming Ding; Xiaoxv Dong; Xingbin Yin; Jian Ni
Journal:  Molecules       Date:  2019-09-16       Impact factor: 4.411

Review 6.  Solubility and Bioavailability Enhancement of Oridonin: A Review.

Authors:  Yuanyuan Zhang; Shaohua Wang; Mengmeng Dai; Jijuan Nai; Liqiao Zhu; Huagang Sheng
Journal:  Molecules       Date:  2020-01-14       Impact factor: 4.411

7.  Preparation of oridonin nanocrystals and study of their endocytosis and transcytosis behaviours on MDCK polarized epithelial cells.

Authors:  Huagang Sheng; Yuanyuan Zhang; Jijuan Nai; Shaohua Wang; Mengmeng Dai; Guitao Lin; Liqiao Zhu; Qiang Zhang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.